Up next

Autoplay

Dr. Wei on the Use of Cabozantinib in Advanced Kidney Cancer

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Xiao X. Wei, MD, MAS, instructor of medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses the side effect profile of cabozantinib (Cabometyx) in advanced kidney cancer.

Show more
0 Comments sort Sort By

Up next

Autoplay